January 18, 2022
RFA-AI-21-021 - Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases (NIAID)
The purpose of this Notice is to inform the extramural community of the early expiration of Funding Opportunity Announcement (FOA) RFA-AI-21-021, "Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)", effective immediately.
Applicants are encouraged to consider applying to the following FOAs:
RFA-AI-21-020 - Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed) for Research Project (Cooperative Agreements)
RFA-AI-21-035 - Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed) for Exploratory/Developmental Grants
Steve Tsang, PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3330
Email: AI-DSFOAinquiries@nih.gov